• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[成人哮喘的当前生理病理概念]

[Present physiopathological concepts of asthma in adults].

作者信息

Michel F B, Godard P, Bousquet J

出版信息

Ann Med Interne (Paris). 1986;137(1):14-6.

PMID:3706954
Abstract

Curiously enough, a kind of curse combined with therapeutic fatalism still hovers over bronchial asthma and a sense of hopelessness may be encountered when faced with this illness. This pessimism is totally unfounded. However, our therapeutic possibilities depend partly on a better understanding of the asthma syndrome. In the past, this condition may not have been recognised for what it is, that is to say a multi factorial syndrome resulting from the innate and the acquired, from specific (allergic) and/or non-specific factors. Undoubtedly, too much responsibility has been placed on the allergic factor in asthma. Although important, it has made us overlook the fact that, allergic or not, asthma is an inflammatory illness of the bronchi provoked by the liberation of mediators. The role of histamine has been well known for a long time and we now realise the importance of the actions of the metabolites of arachidonic acid (prostaglandins and thromboxanes on the one hand, leukotrienes on the other). The characteristics bronchial hyperreactivity observed in asthma may certainly be congenital but this factor may also be acquired as in professional and post-viral asthma. If bronchial asthma remains under-diagnosed and under-treated in France and in Europe it is due to the fact that the artificial distinction between paroxysmal (bronchitis called "asthmatic"), and persistent (that is to say a so-called asthmatic illness), is is often maintained. There is no real ground for maintaining this distinction. Every child with wheezy dyspnea must therefore be the object of a thorough, initial medical examination, including in particular a respiratory function exploration followed by the institution of a long-term, coherent therapeutic strategy.

摘要

说来也怪,一种与治疗宿命论相结合的诅咒仍然笼罩着支气管哮喘,面对这种疾病时可能会感到绝望。这种悲观情绪毫无根据。然而,我们的治疗可能性部分取决于对哮喘综合征的更好理解。过去,这种病症可能未被正确认识,也就是说它是一种由先天和后天、特定(过敏)和/或非特定因素导致的多因素综合征。毫无疑问,在哮喘中,过敏因素被赋予了过多责任。尽管它很重要,但却使我们忽视了这样一个事实,即无论是否过敏,哮喘都是一种由介质释放引发的支气管炎症性疾病。组胺的作用早已为人所知,我们现在也认识到了花生四烯酸代谢产物(一方面是前列腺素和血栓素,另一方面是白三烯)作用的重要性。哮喘中观察到的特征性支气管高反应性可能确实是先天性的,但这个因素也可能是后天获得的,如职业性哮喘和病毒感染后哮喘。在法国和欧洲,支气管哮喘仍然诊断不足且治疗不充分,这是因为阵发性(称为“哮喘性”支气管炎)和持续性(即所谓的哮喘病)之间的人为区分常常被维持。维持这种区分没有实际依据。因此,每个患有喘息性呼吸困难的儿童都必须接受全面的初始医学检查,尤其包括呼吸功能检查,随后制定长期、连贯的治疗策略。

相似文献

1
[Present physiopathological concepts of asthma in adults].[成人哮喘的当前生理病理概念]
Ann Med Interne (Paris). 1986;137(1):14-6.
2
[Etiological factors of asthma and their relation with bronchial hyperreactivity].[哮喘的病因及其与支气管高反应性的关系]
Ann Med Interne (Paris). 1986;137(1):10-3.
3
Mediators of hypersensitivity and inflammatory cells in the pathogenesis of bronchial asthma.支气管哮喘发病机制中的超敏反应介质和炎症细胞
Eur J Respir Dis Suppl. 1983;129:1-44.
4
Mediators and non-specific bronchial hyperreactivity.
Eur J Respir Dis Suppl. 1983;129:95-111.
5
Role of airway reactivity in pathogenesis of asthma.气道反应性在哮喘发病机制中的作用。
Eur J Respir Dis Suppl. 1982;122:29-35.
6
[Bronchial hyperreactivity: state and perspective of drug intervention].[支气管高反应性:药物干预的现状与展望]
Z Erkr Atmungsorgane. 1988;171(1):40-4.
7
[Physiopathological mechanisms in asthma. I. Bronchial hyperreactivity].[哮喘的生理病理机制。I. 支气管高反应性]
Poumon Coeur. 1982 May-Jun;38(3):147-58.
8
[Viruses and asthma].[病毒与哮喘]
Sem Hop. 1983 Nov 24;59(43):2969-74.
9
[Bronchial hyperreactivity: pathomechanisms, diagnosis and perspectives of therapy].
Z Gesamte Inn Med. 1988 Jun 15;43(12):313-9.
10
Non-specific bronchial hyperreactivity: correlation to asthma and modifying factors.
Eur J Respir Dis Suppl. 1984;136:17-24.